Canton Barry's Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Nov 10, 2022
- Accession no.
- 0000899243-22-035554
- Filed
- Nov 10, 2022
- Trade date
- Nov 8-9, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.96M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Canton BarryCIK 0001882756 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | Class A Common Stock | SSaleDisposed | −193,616 | $2.46 | −$476,295.36 | 22,175,747 | Direct | Duplicate filing |
| Nov 8, 2022 | Class A Common Stock | SSaleDisposed | −193,616 | $2.46 | −$476,295.36 | 22,175,747 | Indirect | Duplicate filing |
| Nov 9, 2022 | Class A Common Stock | SSaleDisposed | −207,959 | $2.43 | −$505,340.37 | 21,967,788 | Direct | Duplicate filing |
| Nov 9, 2022 | Class A Common Stock | SSaleDisposed | −207,960 | $2.43 | −$505,342.8 | 21,967,787 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.